NCT06149845

Pulpotomy in Vital Primary Molars Diagnosed With Symptomatic Irreversible Pulpitis

Active, enrolled NA Last updated 31 July 2025

What this trial tests

NA trial testing Full Pulpotomy in Irreversible Pulpitis in 120 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

21 March 2024

Primary endpoint
30 July 2027

31 July 2027

Quick facts

Lead sponsor	Qatar University
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	120
Start date	21 March 2024
Primary completion	30 July 2027
Estimated completion	31 July 2027
Sites	2 locations across Qatar

Drugs / interventions tested

• Full Pulpotomy

Conditions studied

• Irreversible Pulpitis — all drugs for Irreversible Pulpitis →

Sponsor

Qatar University

Who can join

Adults 4 to 9, any sex, with Irreversible Pulpitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a clinical trial to assess the treatment outcomes of pulpotomy in vital primary molars diagnosed with symptomatic irreversible pulpitis. Pulpotomy is a more conservative treatment option over the conventional pulpectomy treatment. Compared to pulpectomy, pulpotomy is a technically simpler procedure, less time consuming, easier for young patients to tolerate, and retains the proprioceptive sensation of the tooth - all important advantages when treating young children.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Pulpotomy for treating primary molars with clinical symptoms indicative of irreversible pulpitis: A prospective single-arm pilot study.
   Philip N, Kowash M, Bani-Hani T, Shahawy OE, et al · · 2025 · PMID 41027503 · DOI 10.1016/j.jdent.2025.106140